TRANSLATE

The all Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the all Hub cannot guarantee the accuracy of translated content. The all and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The ALL Hub is an independent medical education platform, sponsored by Jazz Pharmaceuticals, Amgen, and Pfizer and supported through an educational grant from Servier. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more
 Mark Litzow

Mark Litzow

Steering Committee Member

Mark Litzow is a professor of medicine at the Mayo Clinic. He served as the head of the Acute Leukemia and Myeloid Neoplasm Group at Mayo Clinic's campus in Rochester, Minnesota, for 12 years and the director of the Blood and Marrow Transplant (BMT) Program at Mayo Clinic for 17 years; he remains an active member of both programs. Mark is the chair of the Leukemia Committee of Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN) since 2013. He is also currently the co-chair of the Acute Leukemia Working Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR).

Filter by content: